BI
UTHR icon

Binnacle Investments’s United Therapeutics UTHR Stock Holding History

Binnacle Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$18K Buy
43
+4
+10% +$1.34K 0.01% 300
2025
Q2 		$11.2K Buy
39
+3
+8% +$897 0.01% 348
2025
Q1 		$11.1K Buy
+36
New +$12.3K 0.01% 309

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Binnacle Investments's UTHR Position: Q3 2025 in Review

Binnacle Investments increased its United Therapeutics (UTHR) stake by 10% in Q3 2025, buying an estimated $1.34K and bringing the position to 43 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #300.

Binnacle Investments first reported a position in UTHR in Q1 2025 and has held it in 3 quarters since. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Binnacle Investments held 43 shares of United Therapeutics worth $18K as of Q3 2025.
  • Binnacle Investments bought 4 United Therapeutics shares in Q3 2025, an estimated $1.34K.
  • United Therapeutics made up 0.01% of Binnacle Investments's portfolio in Q3 2025, its #300 holding.
  • Binnacle Investments first reported a position in United Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.